Colibri Heart Valve, LLC to Present Scientific Evidence and Exhibit at Upcoming Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference
10/18/2012 9:10:57 AM
BROOMFIELD, CO, Oct. 18, 2012 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held medical device company, today announced that Dr. Ziyad M. Hijazi will present an update on Colibri's investigational transcatheter aortic valve implantation (TAVI) program at the Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium taking place in Miami Beach, FL from October 22 - 26, 2012. Colibri has developed the world's first and only pre-mounted, pre-crimped, and pre-packaged low profile, 14 French, TAVI system.
comments powered by